Anastrozol Effect: Understanding Its Role in Hormonal Management
Anastrozol, a non-steroidal aromatase inhibitor, plays a crucial role in managing estrogen levels, particularly in postmenopausal women diagnosed with hormone receptor-positive breast cancer. By inhibiting the aromatase enzyme, which converts androgens to estrogen, Anastrozol effectively reduces estrogen production in the body, contributing to improved treatment outcomes for patients undergoing therapies aimed at reducing tumor growth. …
Anastrozol Effect: Understanding Its Role in Hormonal Management Read More »